SCHEMBL20568112

SCHEMBL20568112

CN1CCN(c2cc(NC(=O)Nc3ccc(Oc4ncnc5c4OCCN5)cc3F)cc(C(F)(F)F)c2)CC1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDR P35968 14/20 0.54
BRAF P15056 6/20 0.49
FLT1 P17948 2/20 0.48
AURKA O14965 1/20 0.48
PDGFRB P09619 1/20 0.48
KIT P10721 1/20 0.48
PDGFRA P16234 1/20 0.48
TEK Q02763 1/20 0.48
PTK2 Q05397 1/20 0.48
FGFR1 P11362 1/20 0.46
RET P07949 3/20 0.45
MAP3K7 O43318 1/20 0.45
MAP4K2 Q12851 1/20 0.45
MAPK14 Q16539 1/20 0.44
TNNI3K Q59H18 1/20 0.44
FLT4 P35916 1/20 0.43
RAF1 P04049 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20568092 0.92 RET (0.51) KDRBRAFRETMAP3K7MAP4K2
SCHEMBL20568417 0.87 MAP3K7 (0.56) KDRBRAFKITRETMAP3K7
SCHEMBL20569399 0.85 MAP3K7 (0.51) KDRBRAFRETMAP3K7MAP4K2
SCHEMBL20568109 0.85 RET (0.50) KDRBRAFRETMAP3K7MAP4K2
SCHEMBL20568087 0.85 KDR (0.48) KDRBRAFRETMAP3K7MAP4K2
SCHEMBL20568823 0.85 MAP3K7 (0.54) KDRBRAFPDGFRBKITTEK
SCHEMBL20569381 0.81 KDR (0.48) KDRBRAFRETMAP3K7MAP4K2
SCHEMBL20568408 0.81 MAP4K2 (0.69) BRAFPDGFRBKITMAP3K7MAP4K2
SCHEMBL20569635 0.80 MAP3K7 (0.57) KDRBRAFKITMAP3K7MAP4K2
SCHEMBL20570131 0.80 MAP4K2 (0.59) KDRBRAFKITRETMAP3K7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112601752-A Novel inhibitors of MAP4K1 伊克诺斯科学公司 2021-04-02 CN claimed
EP-3630778-A1 NOVEL INHIBITORS OF MAP4K1 Ichnos Sciences SA (CH) 2020-04-08 EP claimed
WO-2018215668-A1 NOVEL INHIBITORS OF MAP4K1 GLENMARK PHARMACEUTICALS S.A. (CH) 2018-11-29 WO claimed